Abstract The relationship between human cytomegalovirus (HCMV) and glioblastoma (GBM) is an ongoing debate with extensive evidence supporting or refuting its existence through molecular assays, pre-clinical studies, and clinical trials. We focus primarily on the crux of the debate, detection of HCMV in GBM samples using molecular assays. We propose that these differences in detection could be affected by cellular heterogeneity. To take this into account, we align the single-cell RNA sequencing (scRNA-seq) reads from five GBM tumors and two cell lines to HCMV and analyze the alignments for evidence of (i) complete viral transcripts and (ii) low-abundance viral reads. We found that neither tumor nor cell line samples showed conclusive evidence of full HCMV viral transcripts. We also identified low-abundance reads aligned across all tumors, with two tumors having higher alignment rates than the rest of the tumor samples.
Introduction
The nature of the interaction between human cytomegalovirus (HCMV) and glioblastoma (GBM), also called glioblastoma multiforme, is a hotly debated topic in medical research (Cobbs 2015; Dziurzynski et al. 2012; Lawler 2015; Michaelis et al. 2009; Michaelis et al. 2015; Scheurer et al. 2007; Soderberg-Naucler and Johnsen 2015; Wick and Platten 2014) . The core of this debate is whether HCMV infection is associated with GBM etiology, i.e., is HCMV actively initiating and/or driving GBM? To answer this question, numerous researchers investigated the presence of the virus in tumors through different sequencing techniques. Most of this debate stems from the fact that different research groups, often using different assays, have generated evidence to support or refute the presence of HCMV in GBM tumors. There is a large amount of research supporting both sides of this issue (Amirian et al. 2014; Baryawno et al. 2011; Baumgarten et al. 2014; Cosset et al. 2014; Fornara et al. 2016; Hashida et al. 2015; Holdhoff et al. 2015; Joseph et al. 2017; Khoury et al. 2013; Lehrer et al. 2015; Libard et al. 2014; McFalineFigueroa and Wen 2017; Prins et al. 2008; Rahbar et al. 2012; Sardi et al. 2015; Schelhorn et al. 2013; Shamran et al. 2015; Solomon et al. 2014; Stangherlin et al. 2016; Strong et al. 2016; Wolmer-Solberg et al. 2013 ) that we summarize in Fig. 1b-d . One possible explanation is that GBM tumors are heterogeneous on a cellular level in oncogenic signaling, Electronic supplementary material The online version of this article (doi:10.1007/s13365-017-0543-y) contains supplementary material, which is available to authorized users.
proliferation, immune response, and displaying multiple GBM subtypes within the same tumor (Patel et al. 2014; Sottoriva et al. 2013) . Previous groups have shown that viral RNAs can be detected using single-cell RNA sequencing (scRNA-Seq) at measurable expression levels (L. Wu et al. 2015) . Herein, our research group attempted to explain a portion of GBM heterogeneity by differential rates of active HCMV infection within a GBM using single cell sequencing data from approximately 854 single cells and 11 bulk samples derived from five glioblastoma tumors and two GBM cell lines. We hypothesized that small portion of GBM cells might be actively infected by HCMV, masked by an overwhelming majority of uninfected or latently infected cells. However, upon analysis, we observed that none of the cells or bulk samples from any tumor/cell line showed conclusive evidence of complete viral transcripts from HCMV. That means we have not observed sufficient evidence supporting active HCMV infection using single cell sequencing data to support the presence of active virus. We report these findings as they contribute to the discussion on the association between HCMV and GBM.
Methods
Our analysis workflow is shown in Fig. 1a . We downloaded GBM single cell and population RNA sequencing data from Gene Expression Omnibus (GEO, GSE57872), the NIH genomic data repository (Patel et al. 2014) , including data from 854 cells and 11 bulk samples from five GBM tumors and two cell lines. We downloaded 7 HCMV genomes from Genbank, including six published sequences derived from clinical samples, 3157 (GQ221974), JP (GQ221975), HAN13 (GQ221973), HAN20 (GQ396663), HAN38 (GQ396662), and 3301 (GQ466044) (Cunningham et al. 2010) , and the RefSeq sequence (NC006273.2) because it is most regularly used in analysis. We selected HCMV-3157 as a consensus genome representing the six published HCMV sequences, since blocked alignment of the six sequences with MUMmer (Kurtz et al. 2004) showed no major differences between the genomes. The MUMmer alignments can be seen in Fig. S1 where the center diagonal is the positive control (self-comparison) and Escherichia coli and yeast are used as negative controls. We trimmed the virus RNA reads using Trimmomatic (Bolger et al. 2014) , and aligned all reads (Center 1987 ) from all trimmed cells to the HCMV-3157 and HCMV-RefSeq genome, respectively, using the STAR aligner (Dobin et al. 2013) . As further validation, we also aligned the trimmed reads to HCMV-RefSeq genome sequence and quantified transcripts using Sailfish (Patro et al. 2014) .
Next, we investigated the read alignments in search of (i) complete viral transcripts and (ii) low-abundance viral reads. For this purpose, we examined the GBM bulk samples individually in IGV for contiguous alignment regions due to the low number of 11 samples. After analyzing the bulk samples, both sets of alignment files, for HCMV-3157 and HCMVRefSeq sequences, were analyzed separately for potential transcripts.
Identification of complete transcripts
We generated three alignment results for comparison and validation using the following approaches:
Align trimmed reads to HCMV-3157 genome using STAR We removed uninformative polyN 9 reads (reads containing ≥9 consecutive identical nucleotides corresponding to 3 codons) from each single cell's alignment file, thus the resultant files contain only non-polyN 9 reads. polyN 9 reads constitute repetitive regions that will align to both human and HCMV genomes and could be artifacts of polyA tails. To improve the identification of transcripts by boosting sequence depth, all alignment files for each cell were combined into a single alignment file. This combined alignment file was used to create a gtf annotation file with cufflinks (Trapnell et al. 2012) identifying potential transcripts.
Align trimmed reads to HCMV-RefSeq genome using STAR
To account for possible gaps in alignment due to exclusion of polyN 9 reads, all reads inclusive of both polyN 9 and nonpolyN 9 were retained in the alignment files. All individual cell alignment files were combined into a single alignment file which was used to generate a gtf annotation file with cufflinks identifying potential transcripts.
Align trimmed reads to HCMV-RefSeq genome using Sailfish
The Sailfish algorithm combines both the alignment and quantification steps into one due to the kmer strategy of alignment. Sailfish generated a quantification file of transcripts in a single step using the transcript annotation generated from the cufflinks processing of HCMV-RefSeq alignments.
This process produced three files: (i) gtf annotation of all single cell non-polyN 9 reads aligned to HCMV-3157 using STAR, (ii) gtf annotation of all single cell polyN 9 +non-polyN 9 aligned to HCMV-RefSeq using STAR, and (iii) a quantification file of transcripts using Sailfish.
Identification of low-abundance viral reads
After studying the files for complete transcripts, we then searched for evidence of low-abundance viral reads. Lowabundance viral reads constitute reads that align to the viral genome but are too low in abundance and coverage to constitute contiguous transcript. The alignment files for HCMV-3157 were used because they contained the most nonpolyN 9 alignments compared to HCMV-RefSeq. After acquiring the read counts from each bulk sample and single cell, the counts were normalized by the total reads for each cell/sample after trimming to parts per million (ppm). The tumor sample MGH30L was generated from the same tumor as MGH30 but used 100 bp PE reads opposed to 25 bp PE reads resulting in only nine cells with alignments most of which are result of extensive trimming to shorter read lengths. We use MGH30, the 25 bp PE counterpart to MGH30L, as a negative control to address alignment rates related to short read length. We performed Wilcoxon rank-sum tests with Benjamini-Hochberg (BH) correction to identify tumors/cell lines with greater alignment rates than MGH30.
Power analysis
We performed a power analysis using previous positive results as a prior proportion assumption. According to dos Santos, the proportion of positive HCMV is 0.95 (total N = 22) (dos Santos et al. 2014 ). Using seven cell lines achieves 90% power to detect a 29% positive HCMV proportion (two positives) in low-abundance reads at significant level of 0.05 based on fisher exact test (Fleiss et al. 2003) .
Results
The alignment yielded 854 single cell and 11 population alignment files with few informative aligned reads from HCMV. The population level alignments were not analyzed further with Cufflinks because there were too few informative alignments to study individually and too few samples to aggregate. Although there were alignments across all single cell and bulk samples, notably that there are always going to be regions that match in any such analysis. These matched regions often constitute background noise rather than evidence of active HCMV transcription due to sequence homology with human genes (Jenkins et al. 2004; Kotenko et al. 2000) and spurious alignments associated with large transcriptomes (e.g., the expected number of random 17 bp sequences that will align exactly to a random 2 × 10 9 bp sequence is 0.11 see Eq. S1). Alignments can be evaluated by Blast searching the aligned regions against human and viral databases-often aligned regions are not unique to HCMV. The blast alignments of viral aligned regions can be viewed in Figs. S3, S4 , and S5.
We used different sequence alignment pipelines and different HCMV genomes to build predicted transcripts using cufflinks. By comparing the results across methods and genomes, we can more comprehensively evaluate the presence of HCMV in the samples.
Identification of complete transcripts
Aligned trimmed reads to HCMV-3157 using STAR Using this workflow, we were able to align 2,780,276 total reads and 22,285 non-polyN 9 reads to HCMV-3157 across all 854 single cells. Because the read coverage was so low for each cell individually, the only way to proceed was by combining all alignments from each cell into a single alignment file. This combining of many single cell alignments also improves the ability to detect low expression transcripts to a level comparable to bulk RNA-Seq (A. R. Wu et al. 2014) . Transcript generation using Cufflinks produced 25 predicted transcripts with an exon length distribution of min 4 bp, 1st quartile 15.5 bp, median 29 bp, 3rd quartile 42 bp, and max 125 bp. These results show extremely low read coverage to HCMV-3157, less than the number of reads from a single of the 854 cells, resulting in unconvincing predicted transcripts.
Aligned trimmed reads to HCMV-RefSeq genome using STAR
To check that this was not an alignment error specific to HCMV-3157 or due to excluding polyN 9 reads, we used the same workflow with the HCMV-RefSeq sequence. We were able to align 109,974 total reads and 19,905 non-polyN 9 reads to HCMV-RefSeq across all 854 cells. Transcript generation (inclusive of polyN 9 reads) using Cufflinks produced 32 predicted transcripts with an exon length distribution of min 4 bp, 1st quartile 7.5 bp, median 23 bp, 3rd quartile 50.5 bp, and max 312 bp. Even after including uninformative reads, most contiguous regions were still unlikely to produce functional protein product.
Aligned trimmed reads to HCMV-RefSeq genome using Sailfish
Sailfish yielded a higher median aligned reads per cell than STAR, 125 compared to 32 reads, respectively. The estimated number kmers (roughly equivalent to reads) per transcript was still too low to be convincing of viral gene transcription. The maximum kmer per transcript across all cells was 34 with most cells having a maximum kmer per transcript mapping of 3. Since Sailfish is based on k-mer matching as opposed to direct alignment, it is difficult to remove uninformative reads after alignment. Thus, this pipeline produces higher read counts per transcript but it is more difficult to determine signal reads from noise reads after alignment.
Identification of low-abundance viral reads
Single cell sequencing is known to have lower detection rates of RNAs in the lower quartiles of matched bulk samples (Bacher and Kendziorski 2016) . However, if the expression is high enough, there could be utility in scRNA-Seq where low proportions of cells are expressing viral RNA in higher quantiles (Fig. 2a) . Outlier cells (Fig. 2b) could be of use for identifying viral alignments not found in matched bulk samples (Fig. 2d) . MGH30L had virtually no alignments across all single cells sequenced providing evidence; the sample likely does not have active viral infection but MGH30, MGH30L's 25 bp PE counterpart, had higher alignment rates than MGH30L (BH-Wilcoxon p value <0.0001). By considering these aligned reads noise related to short read length, we utilized MGH30 (25 bp PE) as a negative control. We identified MGH26 (BH-Wilcoxon p value = 0.0477) and MGH31 (BHWilcoxon p value = 0.0091) as having higher alignment rates (Fig. 2b) . A similar pattern for MGH31 can be seen in the bulk samples though significance could not be calculated due to low sample size (Fig. 2c) .
Discussion
Based on these findings, we were interested in looking back to see what experimental techniques were used in the published works that had evidence for the presence of HCMV in GBM. A summary of this can be seen in Fig. 1b, c (Amirian et al. 2014; Baryawno et al. 2011; Baumgarten et al. 2014; Cosset et al. 2014; Fornara et al. 2016; Hashida et al. 2015; Holdhoff et al. 2015; Joseph et al. 2017; Khoury et al. 2013; Lehrer et al. 2015; Libard et al. 2014; McFaline-Figueroa and Wen 2017; Prins et al. 2008; Rahbar et al. 2012; Sardi et al. 2015; Schelhorn et al. 2013; Shamran et al. 2015; Solomon et al. 2014; Stangherlin et al. 2016; Strong et al. 2016; WolmerSolberg et al. 2013) . One major finding was that of the articles reviewed only one of those that used RNA-Seq and DNA-Seq as an assay for detection could find viral reads (Solomon et al. 2014) . Note that in the RNA-Seq experiment with positive results, they Bdetected reads at an extremely low-abundance at high sequencing depth and concluded that there was not enough evidence to assume viral etiology^ (Tang et al. 2013) . This finding itself is fascinating since part of the complexity of this problem may lie in the method of detection. All other assay forms have papers on both sides of this debate, and all three major biomolecular units, DNA, RNA, and protein, have both positive and negative assays. This makes us believe that there is something specific to the way that modern sequencing techniques measure the genome and transcriptome that is playing the key role rather than the biomedical unit of measurement. We also look to see if there was a temporal element to this as shown in Fig. 1d . Since the first publications linking HCMV to GBM, there has been an overall trend in more recent publications demonstrating lack of involvement of HCMV in GBM. This could be accounted for by the recent advent of RNA-Seq in the last 10 years (Lister et al. 2008; Mortazavi et al. 2008; Nagalakshmi et al. 2008 ) and more recently the use of RNA-Seq to evaluate the existence of HCMV in glioblastomas that have reduced HCMV detection rates using DNA/RNA-Seq (Fig. 1b) . The increased use of NGS in detection of HCMV in GBM can be seen in Fig. S6 .
Based on the results from this analysis, none of the GBM cells individually had enough non-polyN 9 reads mapped to produce viable protein product. Even when all samples were combined the predicted transcripts are still unconvincing of active viral transcription. We did find variable alignment rates between tumors/cell lines but the alignment rates were so low that they do not provide convincing evidence supporting a viral etiology. There were aligned regions but they did not constitute large contiguous segments of RNA. If further analysis were to be conducted, MGH26 and MGH31 with 100 bp PE at bulk and single cell level with greater sequence depth could be used to more conclusively test for viral transcripts and cellular viral infection heterogeneity.
Another observation was the lack of complexity (length and sequence specificity) of aligned reads. These reads constitute possible viral signal but often lack the complexity to be specific to the virus alone. However, the prevalence of HCMV in the population is high (58%) (Dollard et al. 2011; Staras et al. 2006 ) and we find a small number of segments unique to HCMV which were identified using Blast searches of human and viral databases (Figs. S3, S4, S5) . One of the regions identified (Fig. S3 ) was close in proximity to the location of UL84 in the Towne strain of virus (Dunn et al. 2003) , which has been associated with viral latency (Rossetto at al. 2013; Van Damme and Van Loock 2014) . Both Towne and HCMV-3157 strains had similar genome structure evaluated using MUMmer alignment (Fig. S7) . Due to these considerations, we believe that it is not possible to state a total absence of the virus in these samples. Rather, we believe these alignments are a subset of spurious alignments associated with genome homology and/or sequencing error, degraded sections of viral RNA from previous expression, and low-abundance expression related to latent infection.
The lack of clear virus association in this study brings up unique questions about the nature of GBM and HCMV. It is well established that HCMV is often detected in greater than 90% of sampled GBM patients (Joseph et al. 2017) . The mechanisms causing the high rate of HCMV can even be explained by the deficient immune response in GBM and the ability of HCMV to infect glial cells (McFaline-Figueroa and Wen 2017) . Aside from these direct relationships, clinical trials on the anti-CMV drug Valganciclovir show improved survival times of GBM patients (Soderberg-Naucler et al. 2013) . However, the large amount of variability in reporting of HCMV and GBM (Fig. 1b-d ) taken together with Cidofovir, another HCMV treatment, stimulated apoptosis of HCMV-negative glioblastoma xenografts in mice (Hadaczek et al. 2013) brings about an argument between the ends and means of the HCMV-GBM relationship. HCMV is so prevalent, however, detection by many groups is ineffective and NGS never clearly detects HCMV. Yet, despite the unclear relationship, Valganciclovir is a promising therapeutic for GBM patients.
Further increasing the complexity of this problem, our study did not show that these variable detection rates are an effect of viral tumor heterogeneity-portions of cells were not detected expressing contiguous viral RNA. This is inconsistent with previous research showing viral heterogeneity within viral associated cancer (e.g., HPV and HeLa) (L. Wu et al. 2015) . Like others in this area of research (Joseph et al. 2017) , we believe that the mechanisms surrounding the clinical targeting of HCMV in GBM patients need to be further explored. As shown by multiple trials, there are promising clinical targets but the mechanism of the therapeutic effect is likely not as straightforward as direct targeting of HCMV.
Conclusion
One important element to this analysis is the use of single cell sequencing data. Because single cell sequencing takes into account individual cells as independent entities within a tumor rather than combining cells into a composite mixture, single cell sequencing functionally increases sequencing specificity and depth. Even if a small sub-population within these tumors were actively infected with HCMV, such that composite RNA-Seq would not detect it, scRNA-Seq would be able to identify the sub-population. We did identify MGH26 and MGH31 as having significantly increased alignment rates compared to our control but did not find evidence of complete viral transcripts. Given that we did not identify any cells or bulk samples with contiguous RNA product, it is unlikely that these GBM samples were actively infected with HCMV. We would propose a greater sample size, sequencing depth and 100 bp PE reads for any further analysis of these samples.
